Singleron Biotechnologies is a pioneering molecular diagnostics compay transforming clinical diagnostics, drug development, and health management through advanced single-cell analysis technologies. We offer end-to-end single-cell sequencing solutions, including instruments, reagents, and bioinformatics tools, empowering clinicians and researchers to unlock cellular insights with precision and ease.

“Our mission is to make single cell multi-omics analysis accessible and understandable to all and advance precision medicine 2.0.”

Founded in January 2018, Singleron Biotechnologies is rapidly expanding, establishing offices, labs, and manufacturing facilities across Germany, Singapore, China, and the USA. With its team of over 500 experts, Singleron brings extensive experience from leading multinational corporations.
Singleron’s proprietary technology platform spans the complete single-cell workflow, from tissue preservation and dissociation to cell partitioning, barcoding, library preparation, sequencing support, and bioinformatic analysis. Its innovations include the GEXSCOPE® single-cell system, Matrix® automated processing platforms, CeleScopeTM bioinformatics software, and SynEcoSys® knowledgebase solutions, enabling streamlined and scalable multi-omics research for laboratories worldwide. The company has built a strong intellectual property portfolio with more than 150 patents and patent applications covering microfluidics, instrument automation, single-cell amplification, library construction, data analysis algorithms, and multi-omics
applications. In addition to ready-to-use kits and integrated workflows, Singleron operates multiple global service laboratories that provide expert experimental design, sample processing, sequencing, and publication-ready data analysis. Singleron collaborates with thousands of research institutes, hospitals, biotechnology companies, and pharmaceutical organizations worldwide. Its technologies have supported more than 900 scientific publications, over 9,000 collaborative projects, and the processing of more than 2,000 sample types, contributing to breakthroughs in immunology, oncology, neuroscience, developmental biology, and translational medicine. By combining automation, advanced bioinformatics, and scalable multi-omics solutions, Singleron continues to drive innovation in single-cell biology and bring precision medicine closer to clinical reality.

Find out more:

Find Singleron on Social Media: